Eric Drapé
Chief Operating Officer at TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Net worth: 2 M $ as of 30/03/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yael Ashman | M | - | 15 years | |
| Sol Barer | M | 76 | 9 years | |
| Amir Elstein | M | 67 | 29 years | |
| Mark Sabag | M | 53 | 18 years | |
| Richard Francis | M | 55 | 1 years | |
| Gerald Lieberman | M | 77 | 9 years | |
| Roberto Mignone | M | 52 | 7 years | |
| Varda Shalev | M | 65 | 1 years | |
| Ronit Satchi-Fainaro | M | 52 | 6 years | |
| Rosemary Crane | F | 64 | 9 years | |
| Janet Vergis | F | 59 | 4 years | |
| Amir Weiss | M | 47 | 12 years | |
| Dov Bergwerk | M | - | - | |
| Perry Nisen | M | 68 | 7 years | |
| Tal Zaks | M | 58 | 3 years | |
| Eli Kalif | M | 51 | 5 years | |
| Yonatan Beker | M | - | 11 years | |
| Jacques Brom | M | 59 |
Laboratoire Français du Fractionnement et des Biotechnologies
 Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| Dominique Saint Picq | M | - |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| Yossi Ofek | M | - | - | |
| Eden Klein | M | - | 3 years | |
| Eric Hughes | M | - | 2 years | |
| Kathleen Veit | F | - | 14 years | |
| Jérôme Wacrenier | M | - |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| Aidan Murphy | M | 58 |
Ipsen Manufacturing Ireland Ltd.
 Ipsen Manufacturing Ireland Ltd. BiotechnologyHealth Technology Ipsen Manufacturing Ireland Ltd. operates as a biopharmaceutical group dedicated to improving lives through innovative medicines. The company was founded in 1989 and is headquartered in Dublin, Ireland. | - |
| Laurence Megard | M | - |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| Pascale Augé | M | 53 |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| Jérémie Gue | M | - |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| Christine Lee Fox | F | 56 | 1 years | |
| Richard Daniell | M | 57 | 18 years | |
| Nir Baron | M | - | 10 years | |
| Kelley Dougherty | F | - | 6 years | |
| Ran Meir | M | - | - | |
| Brian E. Shanahan | M | 52 | 22 years | |
| Corinne Fau | F | 62 |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| François Auvigne | M | - |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| Gilles Brisson | M | 72 |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | - |
| Angus J. Grant | M | - | 1 years | |
| Vikki Conway | F | - | 14 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kåre Schultz | M | 62 | 5 years | |
| Richard S. Egosi | M | 61 | 21 years | |
| Dan Suesskind | M | 80 | 6 years | |
| Eyal Desheh | M | 72 | 9 years | |
| Erez Vigodman | M | 64 | 8 years | |
| Shah Hussain | M | 59 | 1 years | |
| Isaac Abravanel | M | 70 | 7 years | |
| Dafna Schwartz | M | 73 | 3 years | |
| Chaim Hurvitz | M | 63 | 15 years | |
| Phillip Frost | M | 87 | 9 years | |
| Marcelo Bigal | M | - | 4 years | |
| Iris Esther Beck Codner | F | 58 | - | |
| Felicia Ladin | F | 52 | 6 years | |
| David M. Stark | M | 55 | 21 years | |
| Maya Michelsohn | F | - | 8 years | |
| Orly Pascal | F | - | 8 years | |
| Craig Marshall Lea | M | 71 | 16 years | |
| Roger Abravanel | M | 77 | 10 years | |
| Sven Dethlefs | M | 55 | 15 years | |
| Jeremy Levin | M | 70 | 1 years | |
| Jean-Michael Halfon | M | 72 | 9 years | |
| Hafrun Fridriksdottir | M | 62 | 6 years | |
| Galia Maor | M | 81 | 6 years | |
| Carlo de Notaristefani | M | 67 | 7 years | |
| Murray Goldberg | M | 79 | 3 years | |
| Chemi Peres | M | 64 | 6 years | |
| Arie Belldegrun | M | 74 | 4 years | |
| Jérôme Martinez | M | 63 |
Université de Paris XI Paris Sud
| 4 years |
| Gianfranco Nazzi | M | - | 7 years | |
| Michele Holcomb | M | 56 | 6 years | |
| Abi Vainstein-Haras | M | 49 | 7 years | |
| Eti Mitrany | F | 54 | 25 years | |
| Ferenc Tracik | M | 60 | 4 years | |
| Michael McClellan | M | 54 | 4 years | |
| Ernesto Aycardi | M | 61 | 4 years | |
| Ivana Magovcevic-Liebisch | M | 55 | 4 years | |
| Edward Barger | M | - | - | |
| Pierre Barrard | M | 58 |
Université de Paris XI Paris Sud
| 4 years |
| Timothy Wright | M | 66 | 2 years | |
| Dalit Hazan | F | 53 | 9 years | |
| Finbar Larkin | M | 66 |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | 16 years |
| Ann Cunningham | F | 56 | 3 years | |
| Itzhak Krinsky | M | 71 | 4 years | |
| Orit Pinchuk | F | 59 | 21 years | |
| Paul Sekhri | M | 65 | 1 years | |
| Harlan Weisman | M | 71 | 2 years | |
| Geneviève Garrigos | M | 68 |
Université de Paris XI Paris Sud
| 3 years |
| Ron Grupel | M | 73 | 21 years | |
| Philippe Dupont | M | 63 |
Université de Paris XI Paris Sud
| 3 years |
| Rémy Hanf | M | - |
Université de Paris XI Paris Sud
| 3 years |
| Domingos Cunha Mota Soares de Oliveira | M | - |
Université de Paris XI Paris Sud
| 4 years |
| Deborah A. Griffin | F | 57 | 20 years | |
| Brendan O'Grady | M | 57 | 10 years | |
| Frances M. Zipp | F | - | 6 years | |
| Jill DeSimone | F | 68 | 2 years | |
| Kobi Altman | M | 55 | 9 years | |
| Esther Lukasiewicz-Hagai | M | - | 1 years | |
| Ron Abraham Mayron | M | 59 | 4 years | |
| Richard Malamut | M | 64 | 3 years | |
| Austin Kim | M | 60 | 11 years | |
| Hanadi Said | F | 47 | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Israel | 83 | 83.00% |
| France | 16 | 16.00% |
| Ireland | 1 | 1.00% |
| Denmark | 0 | -.--% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Eric Drapé
- Personal Network
